Cancer Communications
indexed by SCI
BMC


Research highlight
Targeting mitochondria as an anticancer strategy
Lanfeng Dong & Jiri Neuzil
Cancer Communications 2019 39: 63
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/25/2019   doi:10.1186/s40880-019-0412-6
Original article
Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
Jincheng Feng, Georgios Polychronidis, Ulrike Heger, Giovanni Frongia, Arianeb Mehrabi & Katrin Hoffmann
Cancer Communications 2019 39: 62
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/24/2019   doi:10.1186/s40880-019-0411-7
Mini Review
New frontiers in proton therapy: applications in cancers
Tai-Ze Yuan, Ze-Jiang Zhan & Chao-Nan Qian
Cancer Communications 2019 39: 61
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/22/2019   doi:10.1186/s40880-019-0407-3
Original article
Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database
Gary D. Lewis, Yan Xing, Waqar Haque, Tejal Patel, Mary Schwartz, Albert Chen, Andrew Farach, Sandra S. Hatch, E. Brian Butler, Jenny Chang & Bin S. Teh
Cancer Communications 2019 39: 60
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/21/2019   doi:10.1186/s40880-019-0406-4
Original article
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
Jianhong Peng, Weihao Li, Rongxin Zhang, Junzhong Lin, Jinghua Tang, Yongshan Wen, Zhenhai Lu, Xiaojun Wu & Zhizhong Pan
Cancer Communications 2019 39: 59
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/16/2019   doi:10.1186/s40880-019-0400-x
Original article
Phase II study of R?CCVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin & Cheolwon Suh
Cancer Communications 2019 39: 58
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/16/2019   doi:10.1186/s40880-019-0403-7
Original article
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
Shaoyan Lin, Jian Yue, Xiuwen Guan, Peng Yuan, Jiayu Wang, Yang Luo, Ying Fan, Ruigang Cai, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Fei Ma & Binghe Xu
Cancer Communications 2019 39: 57
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/11/2019   doi:10.1186/s40880-019-0399-z
Letter to the Editor
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
Wen Cai, Biao Cai, Juan Zhou, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue & Jiwei Huang
Cancer Communications 2019 39: 56
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/11/2019   doi:10.1186/s40880-019-0405-5
Original article
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
Yang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, Xiao-Hui Wang, Jin-Bin Chen, Jun-Cheng Wang, Wei He, Yi-Zhen Fu, Li Xu, Min-Shan Chen, Yao-Jun Zhang, Qi-Jiong Li & Zhong-Guo Zhou
Cancer Communications 2019 39: 55
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/11/2019   doi:10.1186/s40880-019-0404-6
Original article
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis
Fei Shao, Xueying Yang, Wei Wang, Juhong Wang, Wei Guo, Xiaoli Feng, Susheng Shi, Qi Xue, Shugeng Gao, Yibo Gao, Zhimin Lu & Jie He
Cancer Communications 2019 39: 54
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/2/2019   doi:10.1186/s40880-019-0401-9

<<    Page 2 of 23  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by BioMed Central

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China